- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05471934
Satisfaction Survey - Cicaplast Mains
Study Overview
Status
Conditions
Detailed Description
The international, open, observational survey is conducted in 3 different countries.
Regarding the statistical analysis, the global satisfaction is described in 5 classes and in 2 classes "Satisfied + Very satisfied" vs. "Neither satisfied nor dissatisfied + Not so satisfied + Not at all satisfied". The 95% Confidence Interval (CI) of the percent of "Satisfied + Very satisfied" is also given.
On patients who already used cream at the inclusion, the following analyses are performed:
- Cross-tabulation between both visits,
- Test of the evolution between both visits using a special procedure for ordinal data with repeated measures,
- Description of a summary variable in 3 classes (Improved / No change / Worsened).
For the analysis of the hands problems, each sign is described at the inclusion and at the evaluation visit. The difference Evaluation-Inclusion is also given. The evolution of the sign is performed by a Wilcoxon test for matched samples.
Study Type
Enrollment (Actual)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- professionals that work on different activities related to hair in a beauty salon
- professionals presenting with current hand problems such as dryness, redness, irritations, cracks and fissures
Exclusion Criteria:
- professionals that do not meet the inclusion criteria
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
satisfaction rate
Time Frame: from baseline to Day28
|
satisfaction questionnaire with a 5-point scale
|
from baseline to Day28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluation of hands problems (dryness, redness, irritations, cracks, fissures)
Time Frame: from baseline to Day28
|
evaluation on a 10-point scale (0 Not at all to 10 Very strong)
|
from baseline to Day28
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LRP14011-CICAPLAST BAUME B5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hand Eczema
-
University Hospital, Gentofte, CopenhagenTrygFonden, DenmarkCompletedChronic Hand Dermatitis | Chronic Hand EczemaDenmark
-
University Hospital Bispebjerg and FrederiksbergStatens Serum InstitutRecruiting
-
BayerCompleted
-
Zealand University HospitalUniversity of Copenhagen; Danish Working Environment FundCompleted
-
University Medical Center GroningenGenzyme, a Sanofi CompanyActive, not recruiting
-
University Medical Center GroningenUnknownHand EczemaNetherlands
-
LEO PharmaCompleted
-
Incyte CorporationActive, not recruitingHand EczemaUnited States, Poland, Canada, Germany
-
Incyte CorporationWithdrawnHand EczemaUnited States, Germany, Spain, Czechia, Canada, Poland